BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

342 related articles for article (PubMed ID: 23973728)

  • 21. Cellular characterization of cells from the Fanconi anemia complementation group, FA-D1/BRCA2.
    Godthelp BC; van Buul PP; Jaspers NG; Elghalbzouri-Maghrani E; van Duijn-Goedhart A; Arwert F; Joenje H; Zdzienicka MZ
    Mutat Res; 2006 Oct; 601(1-2):191-201. PubMed ID: 16920162
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Profiling Fanconi Anemia Gene Mutations among Iranian Patients.
    Esmail Nia G; Fadaee M; Royer R; Najmabadi H; Akbari MR
    Arch Iran Med; 2016 Apr; 19(4):236-40. PubMed ID: 27041517
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Whole-exome sequencing of a rare case of familial childhood acute lymphoblastic leukemia reveals putative predisposing mutations in Fanconi anemia genes.
    Spinella JF; Healy J; Saillour V; Richer C; Cassart P; Ouimet M; Sinnett D
    BMC Cancer; 2015 Jul; 15():539. PubMed ID: 26201965
    [TBL] [Abstract][Full Text] [Related]  

  • 24. From exome analysis in idiopathic azoospermia to the identification of a high-risk subgroup for occult Fanconi anemia.
    Krausz C; Riera-Escamilla A; Chianese C; Moreno-Mendoza D; Ars E; Rajmil O; Pujol R; Bogliolo M; Blanco I; Rodríguez I; Badell I; Ruiz-Castañé E; Surrallés J
    Genet Med; 2019 Jan; 21(1):189-194. PubMed ID: 29904161
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Finnish Fanconi anemia mutations and hereditary predisposition to breast and prostate cancer.
    Mantere T; Haanpää M; Hanenberg H; Schleutker J; Kallioniemi A; Kähkönen M; Parto K; Avela K; Aittomäki K; von Koskull H; Hartikainen JM; Kosma VM; Laasanen SL; Mannermaa A; Pylkäs K; Winqvist R
    Clin Genet; 2015 Jul; 88(1):68-73. PubMed ID: 24989076
    [TBL] [Abstract][Full Text] [Related]  

  • 26. FANCA Gene Mutations with 8 Novel Molecular Changes in Indian Fanconi Anemia Patients.
    Solanki A; Mohanty P; Shukla P; Rao A; Ghosh K; Vundinti BR
    PLoS One; 2016; 11(1):e0147016. PubMed ID: 26799702
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Fanconi's anemia in adulthood: chemoradiation-induced bone marrow failure and a novel FANCA mutation identified by targeted deep sequencing.
    Tan IB; Cutcutache I; Zang ZJ; Iqbal J; Yap SF; Hwang W; Lim WT; Teh BT; Rozen S; Tan EH; Tan P
    J Clin Oncol; 2011 Jul; 29(20):e591-4. PubMed ID: 21519011
    [No Abstract]   [Full Text] [Related]  

  • 28. Generating New FANCA-Deficient HNSCC Cell Lines by Genomic Editing Recapitulates the Cellular Phenotypes of Fanconi Anemia.
    Errazquin R; Sieiro E; Moreno P; Ramirez MJ; Lorz C; Peral J; Ortiz J; Casado JA; Roman-Rodriguez FJ; Hanenberg H; Río P; Surralles J; Segrelles C; Garcia-Escudero R
    Genes (Basel); 2021 Apr; 12(4):. PubMed ID: 33918752
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genetic reversion in an acute myelogenous leukemia cell line from a Fanconi anemia patient with biallelic mutations in BRCA2.
    Ikeda H; Matsushita M; Waisfisz Q; Kinoshita A; Oostra AB; Nieuwint AW; De Winter JP; Hoatlin ME; Kawai Y; Sasaki MS; D'Andrea AD; Kawakami Y; Joenje H
    Cancer Res; 2003 May; 63(10):2688-94. PubMed ID: 12750298
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Quantitative PCR analysis reveals a high incidence of large intragenic deletions in the FANCA gene in Spanish Fanconi anemia patients.
    Callén E; Tischkowitz MD; Creus A; Marcos R; Bueren JA; Casado JA; Mathew CG; Surrallés J
    Cytogenet Genome Res; 2004; 104(1-4):341-5. PubMed ID: 15162062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype-cancer association in patients with Fanconi anemia due to pathogenic variants in FANCD1 (BRCA2) or FANCN (PALB2).
    McReynolds LJ; Biswas K; Giri N; Sharan SK; Alter BP
    Cancer Genet; 2021 Nov; 258-259():101-109. PubMed ID: 34687993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Validation of Fanconi anemia complementation Group A assignment using molecular analysis.
    Moghrabi NN; Johnson MA; Yoshitomi MJ; Zhu X; Al-Dhalimy MJ; Olson SB; Grompe M; Richards CS
    Genet Med; 2009 Mar; 11(3):183-92. PubMed ID: 19367192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Homozygous loss of function BRCA1 variant causing a Fanconi-anemia-like phenotype, a clinical report and review of previous patients.
    Freire BL; Homma TK; Funari MFA; Lerario AM; Leal AM; Velloso EDRP; Malaquias AC; Jorge AAL
    Eur J Med Genet; 2018 Mar; 61(3):130-133. PubMed ID: 29133208
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Severe telomere shortening in Fanconi anemia complementation group L.
    Shah A; George M; Dhangar S; Rajendran A; Mohan S; Vundinti BR
    Mol Biol Rep; 2021 Jan; 48(1):585-593. PubMed ID: 33394227
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A case report and literature review of Fanconi Anemia (FA) diagnosed by genetic testing.
    Solomon PJ; Margaret P; Rajendran R; Ramalingam R; Menezes GA; Shirley AS; Lee SJ; Seong MW; Park SS; Seol D; Seo SH
    Ital J Pediatr; 2015 May; 41():38. PubMed ID: 25953249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Construction of FANCA mutant protein from Fanconi anemia patient and analysis of its function].
    Chen F; Zhang KJ; Zuo XL; Zeng XC
    Zhonghua Xue Ye Xue Za Zhi; 2007 Nov; 28(11):741-4. PubMed ID: 18457264
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnosis of Fanconi anemia in children with atypical clinical features: a primary study.
    Liu R; Hu T; Li JH; Liang C; Gu WY; Shi XD; Wang HX
    Chin Med J (Engl); 2013 Dec; 126(23):4483-6. PubMed ID: 24286411
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutational analysis of FANCL, FANCM and the recently identified FANCI suggests that among the 13 known Fanconi Anemia genes, only FANCD1/BRCA2 plays a major role in high-risk breast cancer predisposition.
    García MJ; Fernández V; Osorio A; Barroso A; Fernández F; Urioste M; Benítez J
    Carcinogenesis; 2009 Nov; 30(11):1898-902. PubMed ID: 19737859
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genotyping of fanconi anemia patients by whole exome sequencing: advantages and challenges.
    Knies K; Schuster B; Ameziane N; Rooimans M; Bettecken T; de Winter J; Schindler D
    PLoS One; 2012; 7(12):e52648. PubMed ID: 23285130
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel Founder Mutation in
    Dimishkovska M; Kotori VM; Gucev Z; Kocheva S; Polenakovic M; Plaseska-Karanfilska D
    Balkan Med J; 2018 Jan; 35(1):108-111. PubMed ID: 29400309
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.